Ensign Peak Advisors, Inc United Therapeutics Corp Transaction History

Ensign Peak Advisors, Inc

$55.3 Billion
Q4 2024

A detailed history of Ensign Peak Advisors, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 37,657 shares of UTHR stock, worth $11.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

37,657

Previous 37,017 1.73%

Holding current value

$11.2 Million

Previous $13.3 Million 0.16%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$348.66 - $410.0 $223,142 - $262,400	640 Added 1.73%	37,657 $13.3 Million
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $1.04 Million - $1.21 Million	3,340 Added 9.92%	37,017 $13.3 Million
Q2 2024 Aug 13, 2024	BUY	$228.26 - $319.04 $1.64 Million - $2.3 Million	7,205 Added 27.22%	33,677 $10.7 Million
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $1.27 Million - $1.5 Million	-6,018 Reduced 18.52%	26,472 $6.08 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $265,591 - $317,577	-1,236 Reduced 3.66%	32,490 $7.14 Million
Q3 2023 Nov 13, 2023	SELL	$211.82 - $248.24 $441,432 - $517,332	-2,084 Reduced 5.82%	33,726 $7.62 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $3.13 Million - $3.55 Million	15,250 Added 74.17%	35,810 $7.91 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $962,288 - $1.25 Million	4,518 Added 28.16%	20,560 $4.6 Million
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $12.4 Million - $16.8 Million	-60,015 Reduced 78.91%	16,042 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $2.36 Million - $2.84 Million	11,615 Added 18.02%	76,057 $15.9 Million
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $129,359 - $178,443	-740 Reduced 1.14%	64,442 $15.2 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $1.11 Million - $1.43 Million	6,675 Added 11.41%	65,182 $11.7 Million
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $2.59 Million - $3.04 Million	-14,053 Reduced 19.37%	58,507 $12.6 Million
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $4.54 Million - $5.42 Million	25,235 Added 53.32%	72,560 $13.4 Million
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $369,067 - $458,828	-2,165 Reduced 4.37%	47,325 $8.49 Million
Q1 2021 May 12, 2021	BUY	$153.94 - $174.85 $201,507 - $228,878	1,309 Added 2.72%	49,490 $8.28 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $26.7 Million - $39.7 Million	-261,873 Reduced 84.46%	48,181 $7.31 Million
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $16.8 Million - $20.4 Million	168,249 Added 118.65%	310,054 $31.3 Million
Q2 2020 Aug 12, 2020	BUY	$92.74 - $125.82 $8.95 Million - $12.1 Million	96,521 Added 213.15%	141,805 $17.2 Million
Q1 2020 May 11, 2020	BUY	$79.39 - $115.35 $602,967 - $876,083	7,595 Added 20.15%	45,284 $4.29 Million
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $2.95 Million - $3.59 Million	37,689 New	37,689 $3.32 Million

Others Institutions Holding UTHR

# of Institutions

717

Shares Held

41.1M

Call Options Held

123K

Put Options Held

100K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc United Therapeutics Corp Transaction History